Navigation Links
Shire plc: Board Changes
Date:12/13/2007

tion efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research; product development including, but not limited to, the successful development of JUVISTA(R) (Human TGFβ3) and GA-GCB (velaglucerase alfa); manufacturing and commercialization including, but not limited to, the launch and establishment in the market of VYVANSE(TM)(lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder ("ADHD")); the impact of competitive products including, but not limited to, the impact of those on Shire's ADHD franchise; patents including, but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval including, but not limited to, the expected product approval date of INTUNIV(TM) (guanfacine extended release) (ADHD); Shire's ability to secure new products for commercialization and/or development; and other risks and uncertainties detailed from time to time in Shire plc's filings with the Securities and Exchange Commission, particularly Shire plc's Annual Report on Form 10-K for the year ended December 31, 2006.


'/>"/>
SOURCE Shire PLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. KGI Elects Three New Members to Board of Trustees
8. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
9. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. BioLife Solutions Expands Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... The maker community is a contemporary ... They focus on learning practical skills while applying them ... bringing their ideas to life via crowdfunding. A subgroup ... making projects using biology. Glowing Plant has worked for ... them glow with bioluminescence genes, and has now pursued ...
(Date:5/23/2013)... May 23, 2013  Saddleback Memorial Medical Center in ... the first hospital on the West Coast to perform ... surgical option provides women with a state-of-the-art, minimally invasive ... Marc Winter , M.D., a highly regarded ... medical director of minimally invasive surgery at Saddleback Memorial, ...
(Date:5/23/2013)... 23, 2013 On April 19th the ... supermarkets to search for the growing antibiotic resistant bacteria ... from a year long study were released late last ... specifically meats, over previous years. For those suffering from ... of antibiotic resistant bacteria in food, may eventually help ...
(Date:5/23/2013)... The New Jersey chapter of the largest organization ... (BDPA), is hosting its 10th annual Families in Technology ... will encourage students and their parents to explore the ... many of the industries’ finest teachers. Held from 9 ... of Technology, the event will include workshops, instruction and ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2
... April 28 Simcere,Pharmaceutical Group (NYSE: SCR ... pharmaceuticals and manufacturer of the patented,anti-cancer biotech product ... Suisse,s 3rd Annual Healthcare Trip, to be held ... and Weihai., Simcere senior management will give ...
... NEW YORK, April 28 Ever been so tired you ... That,s how Holly Jacobson, a nurse,in Clermont, Florida, felt every ... five boys under the age of nine. Nothing a good ... she began experiencing palpitations,breathlessness and fatigue whenever she played with ...
... Corporation,(Nasdaq: ACEL ) today announced that Kuslima Shogen, ... from the company on,or before March 31, 2009. The ... and Alfacell has been terminated., The termination of ... payments from the Company to Ms. Shogen by an ...
Cached Biology Technology:Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip 2D-Ribose Helps Energy-Starved Hearts 2Alfacell Announces Retirement of Chief Executive Officer 2Alfacell Announces Retirement of Chief Executive Officer 3Alfacell Announces Retirement of Chief Executive Officer 4
(Date:5/22/2013)... is responsible for legionellosis, an infectious disease that can ... pathogen has developed a complex method enabling it to ... avoiding these acting against the infectious bacteria. , Research ... in which teams from the National Institute of Health ... in Barcelona (BSC) have also participated, has described for ...
(Date:5/22/2013)... Plastic additives known as phthalates (pronounced THAL-ates) are ... up in flooring, plastic cups, beach balls, plastic ... Disease Control and Preventionthe bodies of most Americans. ... increasing scrutiny. A growing collection of evidence suggests ... packaging and mix with food) may cause significant ...
(Date:5/21/2013)... analysis shows that the nation,s land and water resources ... produce up to 25 billion gallons of algae-based fuel ... country,s yearly needs. , The findings come from an ... needed to grow significant amounts of algae in large, ... the May 7 issue of Environmental Science and ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4
... all osteoporotic hip fractures will occur in Asia by the ... become a major health concern in the region. The ... for the first time in Asia, is an ideal opportunity ... global congress devoted to all aspects of osteoporosis and related ...
... a gene variant known to raise the risk of childhood ... American children, but not in African American children. ... world, asthma is a complex disease in which a variety ... with environmental influences to produce its effects. As in many ...
... a plug and a socket, a nerve and a muscle ... et al published in the Journal of Cell Biology ... both sides of the junction to ensure they fit together ... mouse is functional but simple, with a globular nerve terminal ...
Cached Biology News:IOF World Congress on Osteoporosis in Bangkok to address Asian issues 2More findings on gene involved in childhood asthma 2
TLN2 Antibody...
Olig2 Immunogen: Synthetic peptide from rat. Available Date: 9-19-2006...
...
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215...
Biology Products: